These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
o
|
REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
x
|
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the fiscal year ended December 31, 2013
|
|
o
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
o
|
SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Date of event requiring this shell company report………………..
For the transition period from to
|
|
ISRAEL
|
|
(Jurisdiction of incorporation
or organization)
|
|
None
|
None
|
|
|
Title of each class
|
Name of each exchange on which registered
|
|
|
Ordinary Shares, NIS 0.01 nominal value per share
|
NASDAQ GLOBAL SELECT MARKET
|
|
Large accelerated filer
o
|
Accelerated filer
x
|
Non-accelerated filer
o
|
|
US GAAP
x
|
International Financial Reporting Standards as issued
o
by the International Accounting Standards Board
|
Other
o
|
|
6
|
|
|
6
|
|
|
6
|
|
|
6
|
|
|
Selected Financial Data
|
6
|
|
Risk Factors
|
10
|
|
26
|
|
|
History and Development of the Company
|
26
|
|
Business Overview
|
27
|
|
Organizational Structure
|
36
|
|
Property, Plant and Equipment
|
37
|
|
37
|
|
|
38
|
|
|
Critical Accounting Policies
|
38
|
|
Recently Enacted Accounting Pronouncements Not Yet Adopted
|
41
|
|
Operating Results
|
41
|
|
Liquidity and Capital Resources
|
44
|
|
Research and development, patents and licenses, etc.
|
45
|
|
Trend Information
|
47
|
|
Off-Balance Sheet Arrangements
|
48
|
|
Tabular disclosure of contractual obligations
|
50
|
|
50
|
|
|
Directors and Senior Management
|
50
|
|
Compensation
|
53
|
|
Board Practices
|
55
|
|
Employees
|
67
|
|
Share Ownership
|
69
|
|
70
|
|
|
Major Shareholders
|
70
|
|
Related Party Transactions
|
71
|
|
74
|
|
|
75
|
|
|
Markets and Share Price History
|
75
|
|
77
|
|
|
Memorandum and Articles of Association
|
78
|
|
NASD Marketplace Rules and Home Country Practices
|
87
|
|
Material Contracts
|
89
|
|
Exchange Controls
|
89
|
|
Taxation
|
89
|
|
Documents on Display
|
103
|
|
104
|
|
|
Interest Rate Risk
|
104
|
|
Foreign Currency Exchange Risk
|
104
|
|
106
|
|
|
106
|
|
|
106
|
|
|
106
|
|
106
|
|
|
Disclosure Controls and Procedures
|
106
|
|
Management's Annual Report on Internal Control over Financial Reporting
|
107
|
|
Inherent Limitations on Effectiveness of Controls
|
107
|
|
Changes in Internal Control over Financial Reporting
|
107
|
|
107
|
|
|
108
|
|
|
108
|
|
|
108
|
|
|
109
|
|
|
109
|
|
|
109
|
|
|
109
|
|
|
111
|
|
|
112
|
|
|
112
|
|
|
112
|
|
|
113
|
|
Year Ended December 31
In US$ Thousands
|
||||||||||||||||||||
|
2009
|
2010
|
2011
|
2012
|
2013
|
||||||||||||||||
|
Sales
|
$ | 20,526 | $ | 30,399 | $ | 39,633 | $ | 48,729 | $ | 73,298 | ||||||||||
|
Cost of sales
|
12,461 | 17,490 | 22,430 | 28,849 | 43,865 | |||||||||||||||
|
Gross profit
|
8,065 | 12,909 | 17,203 | 19,880 | 29,433 | |||||||||||||||
|
Research and development costs
|
2,716 | 3,280 | 4,165 | 4,401 | 5,465 | |||||||||||||||
|
Sales and marketing expenses
|
1,821 | 2,207 | 2,677 | 3,081 | 3,818 | |||||||||||||||
|
General and administrative expenses
|
1,313 | 1,523 | 1,890 | 2,369 | 2,572 | |||||||||||||||
|
Total operating expenses
|
5,850 | 7,010 | 8,732 | 9,851 | 11,855 | |||||||||||||||
|
Operating income
|
2,215 | 5,899 | 8,471 | 10,029 | 17,578 | |||||||||||||||
|
Financial income, net
|
909 | 617 | 439 | 752 | 404 | |||||||||||||||
|
Income before income taxes
|
3,124 | 6,516 | 8,910 | 10,781 | 17,982 | |||||||||||||||
|
Income tax expenses
|
305 | 801 | 667 | 910 | 905 | |||||||||||||||
|
Net income
(1)
|
2,819 | 5,715 | 8,243 | 9,871 | 17,077 | |||||||||||||||
|
Income per share
|
||||||||||||||||||||
|
Basic income per ordinary share
|
$ | 0.420 | $ | 0.838 | $ | 1.195 | $ | 1.424 | $ | 2.404 | ||||||||||
|
Diluted income per ordinary share
|
$ | 0.412 | $ | 0.824 | $ | 1.178 | $ | 1.417 | $ | 2.357 | ||||||||||
|
Weighted average number of ordinary shares used to compute basic income per share (in thousands)
|
6,720 | 6,821 | 6,896 | 6,934 | 7,103 | |||||||||||||||
|
Weighted average number of ordinary shares used to compute diluted income per share (in thousands)
|
6,843 | 6,938 | 6,995 | 6,968 | 7,246 | |||||||||||||||
|
2009
|
2010
|
2011
|
2012
|
2013
|
||||||||||||||||
|
Total assets
|
$ | 55,591 | $ | 63,479 | $ | 72,865 | $ | 89,033 | $ | 105,257 | ||||||||||
|
Total current liabilities
|
$ | 4,399 | $ | 5,827 | $ | 6,438 | $ | 11,789 | $ | 11,948 | ||||||||||
|
Long-term liability
|
$ | 1,967 | $ | 2,222 | $ | 2,153 | $ | 2,278 | $ | 2,618 | ||||||||||
|
Shareholders' equity
|
$ | 49,225 | $ | 55,430 | $ | 64,274 | $ | 74,966 | $ | 90,691 | ||||||||||
|
Capital stock
|
$ | 20 | $ | 20 | $ | 20 | $ | 21 | $ | 21 | ||||||||||
|
Number of ordinary shares issued
(1)
|
6,824,284 | 6,894,659 | 6,940,059 | 7,022,397 | 7,154,984 | |||||||||||||||
|
HIGH
|
LOW
|
|||||||
|
February 2014
|
3.549 | 3.496 | ||||||
|
January 2014
|
3.507 | 3.483 | ||||||
|
December 2013
|
3.530 | 3.471 | ||||||
|
November 2013
|
3.569 | 3.519 | ||||||
|
October 2013
|
3.567 | 3.518 | ||||||
|
September 2013
|
3.632 | 3.504 | ||||||
|
2013
|
3.611
|
|
2012
|
3.844
|
|
2011
|
3.582
|
|
2010
|
3.732
|
|
2009
|
3.927
|
|
|
·
|
Substantial research and development and business development expenditures, which could divert funds from other corporate uses and/or have a significant negative effect on our short-term results;
|
|
|
·
|
Diversion of management’s attention from our core business; and
|
|
|
·
|
Entering markets in which we have little or no experience.
|
|
|
·
|
Post-merger integration problems resulting from the combination of any acquired operations with our own operations or from the combination of two or more operations into a new merged entity;
|
|
|
·
|
Diversion of management’s attention from our core business;
|
|
|
·
|
Substantial expenditures, which could divert funds from other corporate uses;
|
|
|
·
|
Entering markets in which we have little or no experience; and
|
|
|
·
|
Loss of key employees of the acquired operations.
|
|
|
(i)
|
High-end server network interface cards with and without bypass (Server Adapters);
|
|
|
(ii)
|
Intelligent and programmable cards, with features such as encryption, acceleration, data compression, redirection, time stamping and/or other offload features (Smart Adapters);
|
|
|
(iii)
|
Stand-alone Bypass Switches (mostly Intelligent bypass switches); and
|
|
|
(iv)
|
The patented SETAC (Server To Appliance Converter) product family, a unique solution that enables standard servers to be configured as network appliances with high-density front networking ports and easy port modularity.
|
|
|
(i)
|
Network appliances, including WAN optimization, internet security, application delivery, Traffic Management and network monitoring;
|
|
|
(ii)
|
Servers;
|
|
|
(iii)
|
Data storage including Big Data; and
|
|
|
(iv)
|
The “Cloud” (virtualized data centers with and without SDN).
|
|
|
·
|
We approach a potential customer or are approached by such customer.
|
|
|
·
|
If the customer shows interest in the products and we believe that achievement of a business relationship with the customer is possible, we ship products for such customer’s evaluation.
|
|
|
·
|
During the evaluation process the customer receives a few units of the relevant product for initial basic testing. If the evaluation process is successful, we ship products for qualification.
|
|
|
·
|
During the qualification process the customer receives a larger amount of our products for more specific testing, which may include certain adaptations of our products to its specific needs.
|
|
|
·
|
If the qualification process is successful, we enter into negotiations regarding the terms of a business relationship.
|
|
|
·
|
In some cases, typically with the larger customers, the evaluation and qualification process may take 12 months or more.
|
|
·
|
Inventories - Inventories are stated at the lower of cost or market. Cost is determined using the "average-cost" method. We write down obsolete or slow moving inventory to its market value.
|
|
·
|
Marketable securities – We account for investments which we intend and are able to hold to maturity, that are classified as held-to-maturity investments as defined in ASC 320-10, “Accounting for Certain Investments in Debt and Equity Securities”.
|
|
·
|
Allowance for doubtful accounts - Trade receivables are recorded less the related allowance for doubtful accounts receivable. We consider accounts receivable to be doubtful when it is probable that we will be unable to collect all amounts, taking into account current information and events regarding our customers' ability to repay their obligations. The balance sheet allowance for doubtful debts is determined as a specific amount for those accounts the collection of which is uncertain. We perform our estimates regarding potential doubtful debts based on payment history and correspondence with our customers, and based on new information we receive about the customers’ financial situation. As of December 31, 2013, the allowance for doubtful debts was $20 thousand.
|
|
·
|
Deferred Taxes - We account for income taxes under ASC 740-10 (formally known as SFAS No. 109), "Accounting for Income taxes". Under ASC 740-10, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases, and operating loss and tax credit carry forwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. Valuation allowances are established when necessary to reduce deferred taxes assets to the amount expected to be realized. Valuation allowances in respect of deferred taxes were recorded in respect of the following matter:
|
|
§
|
Deferred tax assets that, as we believe, are more likely than not to be realized. In assessing the potential of realization of deferred tax assets, we consider projected future taxable income and tax planning strategies.
|
|
·
|
Impairment or disposal of long lived assets - We account for long-lived assets in accordance with the provisions of ASC subtopic 360-10 (SFAS No. 144), “Property plant and equipment - overall”. This Statement requires that long-lived assets be reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to future undiscounted net cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds its estimated future cash flows, an impairment charge is recognized for the amount by which the carrying amount of the asset exceeds the fair value of the asset. Fair value is being determined using discounted cash flow models. Assets to be disposed would be separately presented in the balance sheet and reported at the lower of the carrying amount or fair value less costs to sell.
|
|
·
|
Accounting for Stock-Based Compensation - The Company recognizes compensation expense in accordance with ASC topic 718, "Compensation – stock compensation" based on estimated grant date fair value using an option-pricing model. The share-based awards granted after January 1, 2008 include features that are not supported by the Black and Scholes valuation model, such as an expiration date to occur if the closing price of the Shares falls below 50% of the grant date Share price. Therefore for share-based awards granted after January 1, 2008, the Company recognizes compensation expense based on estimated grant date fair value using the Monte Carlo option-pricing model, or the Binomial option-pricing model.
|
|
2011
|
2012
|
2013
|
||||||||||
|
Sales
|
100 | % | 100 | % | 100 | % | ||||||
|
Cost of sales
|
56.6 | 59.2 | 59.8 | |||||||||
|
Gross profit
|
43.4 | 40.8 | 40.2 | |||||||||
|
Research and development costs
|
10.5 | 9.0 | 7.5 | |||||||||
|
Selling and marketing expenses
|
6.7 | 6.3 | 5.2 | |||||||||
|
General and administrative expenses
|
4.8 | 4.9 | 3.5 | |||||||||
|
Operating Income
|
21.4 | 20.6 | 24.0 | |||||||||
|
Financial income, net
|
1.1 | 1.5 | 0.5 | |||||||||
|
Income before income taxes
|
22.5 | 22.1 | 24.5 | |||||||||
|
Income tax expenses
|
1.7 | 1.8 | 1.2 | |||||||||
|
Net Income
|
20.8 | 20.3 | 23.3 | |||||||||
|
Payments due by period
|
||||||||||||||||||||
|
Contractual Obligations
|
Total
|
Less than 1 year
|
1-3 years
|
3-5 years
|
More than 5 years
|
|||||||||||||||
|
Operating Leases
|
2,069,000 | 944,000 | 1,125,000 | |||||||||||||||||
|
Purchase Obligations
|
11,944,000 | 11,944,000 | ||||||||||||||||||
|
Total
|
14,013,000 | 12,888,000 | 1,125,000 | |||||||||||||||||
|
Name
|
Age
|
Position with Company
|
|
Avi Eizenman
|
56
|
Active Chairman of the Board
|
|
Shaike Orbach
|
62
|
President, Chief Executive Officer, Director
|
|
Zohar Zisapel
|
65
|
Director
|
|
Einat Domb-Har
|
46
|
External Director during part of 2013 (final three year term ended as of July 1, 2013)
|
|
Ayelet Aya Hayak
|
44
|
External Director commencing as of July 1, 2013
|
|
Ilan Erez
|
46
|
External Director
|
|
Eran Gilad
|
46
|
Chief Financial Officer
|
|
|
·
|
an employment relationship;
|
|
|
·
|
a business or professional relationship maintained on a regular basis;
|
|
|
·
|
control; and
|
|
|
·
|
service as an office holder.
|
|
|
·
|
the majority includes at least a majority of the shares held by non-controlling and disinterested shareholders who are present and voting at the meeting; or
|
|
|
·
|
the total number of shares held by non-controlling and disinterested shareholders that voted against the election of the director does not exceed two percent of the aggregate voting rights in the company.
|
|
|
·
|
The chairman of the board of directors,
|
|
|
·
|
Any director employed by or otherwise providing services to the company or to the controlling shareholder or entity under such controlling shareholder's control,
|
|
|
·
|
Any director who derives his salary primarily from a controlling shareholder,
|
|
|
·
|
A controlling shareholder, or
|
|
|
·
|
Any relative of a controlling shareholder.
|
|
|
·
|
The chairman of the board of directors,
|
|
|
·
|
Any director employed by or otherwise providing services to the company or to the controlling shareholder or entity under such controlling shareholder's control,
|
|
|
·
|
Any director who derives his salary primarily from a controlling shareholder,
|
|
|
·
|
A controlling shareholder, or
|
|
|
·
|
Any relative of a controlling shareholder.
|
|
|
1.
|
To recommend to the Board of Directors as to a compensation policy for officers of the company, as well as to recommend, once every three years to extend the compensation policy subject to receipt of the required corporate approvals;
|
|
|
2.
|
To recommend to the Board of Directors as to any updates to the compensation policy which may be required;
|
|
|
3.
|
To review the implementation of the compensation policy by the Company;
|
|
|
4.
|
To approve transactions relating to terms of office and employment of certain Company office holders, which require the approval of the compensation committee pursuant to the Companies Law; and
|
|
|
5.
|
To exempt, under certain circumstances, a transaction relating to terms of office and employment from the requirement of approval of the shareholders meeting.
|
|
|
a.
|
advancement of the goals of the Company, its working plan and its long term policy;
|
|
|
b.
|
the creation of proper incentives for the office holders while taking into consideration, inter alia, the Company’s risk management policies;
|
|
|
c.
|
the Company’s size and nature of its operations;
|
|
|
d.
|
the contributions of the relevant office holders in achieving the goals of the Company and profit in the long term in light of their positions;
|
|
|
e.
|
the education, skills, expertise and achievements of the relevant office holders;
|
|
|
f.
|
the role of the office holders, areas of their responsibilities and previous agreements with them;
|
|
|
g.
|
the correlation of the proposed compensation with the compensation of other employees of the Company, and the effect of such differences in compensation on the employment relations in the company; and
|
|
|
h.
|
the long term performance of the office holder.
|
|
|
(i)
|
the majority of the votes includes at least a majority of all the votes of shareholders who are not controlling shareholders of the company or who do not have a personal interest in the compensation policy and participating in the vote; abstentions shall not be included in the total of the votes of the aforesaid shareholders; or
|
|
|
(ii)
|
the total of opposing votes from among the shareholders described in subsection (i) above does not exceed 2% of all the voting rights in the company
.
|
|
As of December 31
|
2011
|
2012
|
2013
|
|||||||||
|
Total Employees
|
96 | 111 | 143 | |||||||||
|
Marketing, Sales, Customer Services
|
12 | 14 | 17 | |||||||||
|
Research & Development
|
31 | 37 | 41 | |||||||||
|
Manufacturing
|
44 | 51 | 75 | |||||||||
|
Corporate Operations and Administration
|
9 | 9 | 10 | |||||||||
|
Name and Address
|
Number of Shares and Options Owned
1
|
Percent of Outstanding Shares
|
||||||
|
Zohar Zisapel
2
|
1,511,722 | 21.05 | % | |||||
|
Avi Eizenmann
|
202,618 | 2.82 | % | |||||
|
Shaike Orbach
|
* | * | ||||||
|
Einat Domb Har
|
* | * | ||||||
|
Ayelet Aya Hayak
|
* | * | ||||||
|
Ilan Erez
|
* | * | ||||||
|
Eran Gilad
|
* | * | ||||||
|
All directors and officers as a group
|
1,714,340 | 23.87 | % | |||||
|
Name of Shareholder
|
Number of Shares and Options Owned
1
|
Percentage of Outstanding Shares
|
||||||
|
Zohar Zisapel
2
|
1,511,722 | 21.05 | % | |||||
|
Dov Yelin/Yair Lapidot/Yelin Lapidot Holdings Management Ltd.
3
|
421,902 | 5.87 | % | |||||
|
PERIOD
|
HIGH
|
LOW
|
||||||
|
LAST 6 CALENDAR MONTHS
|
||||||||
|
February 2014
|
72.18 | 61.10 | ||||||
|
January 2014
|
63.91 | 44.98 | ||||||
|
December 2013
|
45.82 | 40.20 | ||||||
|
November 2013
|
46.15 | 42.10 | ||||||
|
October 2013
|
45.17 | 33.84 | ||||||
|
September 2013
|
37.16 | 30.83 | ||||||
|
FINANCIAL QUARTERS DURING THE PAST TWO YEARS
|
||||||||
|
Fourth Quarter 2013
|
46.15 | 33.84 | ||||||
|
Third Quarter 2013
|
42.40 | 29.85 | ||||||
|
Second Quarter 2013
|
35.50 | 25.50 | ||||||
|
First Quarter 2013
|
28.90 | 17.97 | ||||||
|
Fourth Quarter 2012
|
18.50 | 15.15 | ||||||
|
Third Quarter 2012
|
15.70 | 13.59 | ||||||
|
Second Quarter 2012
|
17.99 | 13.11 | ||||||
|
First Quarter 2012
|
20.33 | 15.77 | ||||||
|
FIVE MOST RECENT FULL FINANCIAL YEARS
|
||||||||
|
2013
|
46.15 | 17.97 | ||||||
|
2012
|
20.33 | 13.11 | ||||||
|
2011
|
21.91 | 12.17 | ||||||
|
2010
|
19.54 | 8.02 | ||||||
|
2009
|
10.20 | 4.11 | ||||||
|
PERIOD
|
HIGH
|
LOW
|
||||||
|
LAST SIX CALENDAR MONTHS
|
||||||||
|
February 2014
|
216.00 | 250.90 | ||||||
|
January 2014
|
221.90 | 157.00 | ||||||
|
December 2013
|
160.50 | 140.00 | ||||||
|
November 2013
|
162.60 | 152.00 | ||||||
|
October 2013
|
166.60 | 123.80 | ||||||
|
September 2013
|
128.80 | 114.00 | ||||||
|
FINANCIAL QUARTERS DURING THE PAST TWO YEARS
|
||||||||
|
Fourth Quarter 2013
|
166.60 | 123.80 | ||||||
|
Third Quarter 2013
|
152.00 | 108.60 | ||||||
|
Second Quarter 2013
|
128.60 | 90.01 | ||||||
|
First Quarter 2013
|
109.80 | 66.50 | ||||||
|
Fourth Quarter 2012
|
72.77 | 58.85 | ||||||
|
Third Quarter 2012
|
62.00 | 53.01 | ||||||
|
Second Quarter 2012
|
69.69 | 51.60 | ||||||
|
First Quarter 2012
|
73.00 | 60.31 | ||||||
|
FIVE MOST RECENT FULL FINANCIAL YEARS
|
||||||||
|
2013
|
166.60 | 66.50 | ||||||
|
2012
|
73.00 | 51.60 | ||||||
|
2011
|
80.64 | 44.16 | ||||||
|
2010
|
71.20 | 30.31 | ||||||
|
2009
|
44.44 | 16.20 | ||||||
|
|
·
|
appointment or termination of our auditors;
|
|
|
·
|
appointment and dismissal of external directors;
|
|
|
·
|
approval of interested party acts and transactions requiring general meeting approval as provided in sections 255 and 268 to 275 of the Israeli Companies Law;
|
|
|
·
|
a merger as provided in section 320(a) of the Israeli Companies Law;
|
|
|
·
|
the exercise of the powers of the board of directors, if the board of directors is unable to exercise its powers and the exercise of any of its powers is vital for our proper management, as provided in section 52(a) of the Israeli Companies Law;
|
|
|
·
|
amendments to our articles of association;
|
|
|
·
|
approving an increase or decrease of the registered share capital.
|
|
|
·
|
all of the directors are permitted to vote on the matter and attend the meeting in which the matter is considered; and
|
|
|
·
|
the matter requires approval of the shareholders at a general meeting.
|
|
|
·
|
A private placement that meets all of the following conditions:
|
|
|
°
|
The private placement will increase the relative holdings of a shareholder that holds five percent or more of the company’s outstanding share capital, assuming the exercise of all of the securities convertible into shares held by that person, or that will cause any person to become, as a result of the issuance, a holder of more than five percent of the company's outstanding share capital.
|
|
|
°
|
20 percent or more of the voting rights in the company prior to such issuance are being offered.
|
|
|
°
|
All or part of the consideration for the offering is not cash or registered securities, or the private placement is not being offered at market terms.
|
|
|
·
|
A private placement which results in anyone becoming a controlling shareholder of the public company.
|
|
|
·
|
any amendment to the articles of association;
|
|
|
·
|
an increase of the company’s authorized share capital;
|
|
|
·
|
a merger; or
|
|
|
·
|
approval of interested party acts and transactions that require general meeting approval as provided in sections 255 and 268 to 275 of the Israeli Companies Law.
|
|
|
·
|
Code of Corporate Governance.
Under the Sixteenth Amendment, a code of recommended corporate governance practices has been attached as an annex to the Companies Law. In the explanatory notes to the legislation, the Knesset noted that an "adopt or disclose non-adoption" regulation would be issued by the Israeli Securities Authority with respect to such code. As of the date of this Annual Report, the Israeli Securities Authority has issued reporting instructions with respect to this code which are applicable only to publicly traded companies whose securities are traded solely on the Tel Aviv Stock Exchange and which report solely to the Israeli Securities Authority.
|
|
|
·
|
Fines.
The Israeli Securities Authority shall be authorized to impose fines on any person or company performing a violation, in connection with a publicly traded company which reports to the Israeli Securities Authority, and specifically designated as a violation under the Sixteenth Amendment.
|
|
|
·
|
Distribution of annual and quarterly reports to shareholders
– Under Israeli law we are not required to distribute annual and quarterly reports directly to shareholders and the generally accepted business practice in Israel is not to distribute such reports to shareholders. We do however make our audited financial statements available to our shareholders prior to our annual general meeting and furnish our quarterly and annual financial results with the Securities and Exchange Commission on Form 6-K.
|
|
|
·
|
Independence, Nomination and Compensation of Directors
– A majority of our board of directors may not necessarily be comprised of independent directors as defined in NASDAQ Listing Rule 5605(a)(2). Our board of directors contains two external directors in accordance with the provisions of the Israeli Companies Law. Israeli law does not require, nor do our external directors conduct, regularly scheduled meetings at which only they are present. In addition, with the exception of our external directors, our directors are elected for terms of one year or until the following annual meeting, by a general meeting of our shareholders. The nominations for director which are presented to our shareholders are generally made by our board of directors. One or more shareholders of a company holding at least one percent of the voting power of the company may nominate a currently serving external director for an additional three year term. Israeli law does not require the adoption of and our board has not adopted a formal written charter or board resolution addressing the nomination process and related matters. Compensation of our directors and other officers of the Company is determined in accordance with Israeli law.
|
|
|
·
|
Audit Committee
– Our audit committee does not meet with all the requirements of NASDAQ Listing Rule 5605. We are of the opinion that the members of our audit committee comply with the requirements of NASDAQ Listing Rule 5605(c)(3) and Rule 10A-3(b) of the general rules and regulations promulgated under the Securities Act of 1933 and all requirements under Israeli law. Our audit committee has not adopted a formal written audit committee charter specifying the items enumerated in NASDAQ Listing Rule 5605(c)(1).
|
|
|
·
|
Compensation Committee
-
We follow the provisions of the Israeli Companies Law with respect to matters in connection with the composition and responsibilities of our compensation committee, office holder compensation, and any required approval by the shareholders of such compensation. Israeli law, and our amended and restated articles of association, do not require that a compensation committee composed solely of independent members of our board of directors determine (or recommend to the board of directors for determination) an executive officer’s compensation, as required under NASDAQ’s recently adopted listing standards related to compensation committee independence and responsibilities; nor do they require that the Company adopt and file a compensation committee charter. Instead, our compensation committee has been established and conducts itself in accordance with provisions governing the composition of and the responsibilities of a compensation committee as set forth in the Israeli Companies Law. Furthermore, the compensation of office holders is determined and approved by our compensation committee and our board of directors, and in certain circumstances by our shareholders, either in consistency with our previously approved Executive Compensation Policy or, in special circumstances in deviation therefrom, taking into account certain considerations set forth in the Israeli Companies Law. The requirements for shareholder approval of any office holder compensation, and the relevant majority or special majority for such approval, are all as set forth in the Israeli Companies Law. Thus, we will seek shareholder approval for all corporate actions with respect to office holder compensation requiring such approval under the requirements of the Israeli Companies Law, including seeking prior approval of the shareholders for the Executive Compensation Policy and for certain office holder compensation, rather than seeking approval for such corporate actions in accordance with NASDAQ Listing Rules.
|
|
|
·
|
Quorum
– Under Israeli law a company is entitled to determine in its articles of association the number of shareholders and percentage of holdings required for a quorum at a shareholders meeting. Our Articles of Association provide that a quorum of two or more shareholders, present in person or by proxy, holding shares conferring in the aggregate more than thirty three and a third (33 1/3 %) percent of the voting power of the Company is required for commencement of business at a general meeting.
|
|
|
·
|
Approval of Related Party Transactions
– All related party transactions are approved in accordance with the requirements and procedures for approval of interested party acts and transactions, set forth in sections 268 to 275 of the Israeli Companies Law-1999.
|
|
|
·
|
Shareholder Approval
– We seek shareholder approval for all corporate action requiring such approval, in accordance with the requirements of the Israeli Companies Law – 1999.
|
|
|
·
|
Equity Compensation Plans
- We do not necessarily seek shareholder approval for the establishment of, and amendments to, stock option or equity compensation plans (as set forth in NASDAQ Listing Rule 5635(c)), as such matters are not subject to shareholder approval under Israeli law. We will attempt to seek shareholder approval for our stock option or equity compensation plans (and the relevant annexes thereto) to the extent required in order to ensure they are tax qualified for our employees in the United States. However, even if such approval is not received, then the stock option or equity compensation plans will continue to be in effect, but the Company will be unable to grant options to its U.S. employees that qualify as Incentive Stock Options for U.S. federal tax purpose. Our stock option or other equity compensation plans are also available to our non-U.S. employees, and provide features necessary to comply with applicable non-U.S. tax laws.
|
|
|
·
|
Replacement of all future tax incentives under the existing law as amended by the First Amendment; as a result, commencing 2011, industrial companies that meet the conditions set out by the Second Amendment will no longer be entitled to the existing tax incentives provided under the First Amendment, such as the exemption from tax on undistributed profits and a reduced tax rate thereafter, but rather to the tax incentives under the Second Amendment.
|
|
|
·
|
Under the transition provisions, any tax benefits obtained prior to 2011 shall continue to apply until expired, unless the company elects to apply the provisions of the Second Amendment to its income.
|
|
|
·
|
Pursuant to the second Amendment, a Preferred Enterprise is entitled to a reduced corporate flat tax rate of 15% with respect to its preferred income derived by its Preferred Enterprise in 2011-2012, unless the Preferred Enterprise is located in a certain development zone, in which case the rate will be 10%. Such corporate tax rates will be changed to 12.5% and 7%, in 2013 and to 16% and 9% in 2014 and thereafter. Income derived by a Preferred Company from a ‘Special Preferred Enterprise’ (as such term is defined in the Investment Law) would be entitled, during a benefits period of 10 years, to further reduced tax rates of 8%, or to 5% if the Special Preferred Enterprise is located in a certain development zone. Under the Second Amendment, the tax incentives offered by the Investment Law are no longer dependant neither on minimum qualified investments nor on foreign ownership.
|
|
|
·
|
Companies will be able to enjoy both government grants and tax benefits concurrently. Governmental grants will not necessarily be dependent on the extent of enterprise’s investment in assets and/or equipment. Commencing 2011, the approval of “Preferred Enterprise” status by either the Israeli Tax Authorities or the Investment Center will be accepted by the other. Therefore a Preferred Enterprise will be eligible to receive both tax incentives and government grants, under certain conditions.
|
|
Source
|
% of Dividend
|
Individual Tax %
|
Corporations Tax %
|
Foreign Resident Tax %
|
||||||||||||
|
Regular Income
|
34.60310 | 25 | 0 | 25 | ||||||||||||
|
Benefited Enterprise
|
65.3969 | 15 | 15 | 15 | ||||||||||||
|
2012
|
2013
|
|||||||
|
Audit Fees(1)
|
$ | 105,000 | $ | 105,000 | ||||
|
Audit-Related Fees(2)
|
$ | 33,000 | $ | 8,000 | ||||
|
Tax Fees(3)
|
$ | 38,000 | $ | 31,000 | ||||
|
|
·
|
We are not required to distribute annual and quarterly reports directly to shareholders, but we do make our audited financial statements available to our shareholders prior to our annual general meeting and furnish our quarterly and annual financial results with the Securities and Exchange Commission on Form 6-K.
|
|
|
·
|
A majority of our board of directors may not necessarily be comprised of independent directors as defined in the NASDAQ Listing Rules, but our board of directors contains two external directors in accordance with the Israeli Companies Law – 1999. Israeli law does not require, nor do our external directors conduct, regularly scheduled meetings at which only they are present. In addition, with the exception of our external directors, our directors are elected for terms of one year or until the following annual meeting, by a general meeting of our shareholders. The nominations for director which are presented to our shareholders are also generally made by our board of directors. Pursuant to the Israeli Companies Law, one or more shareholders of a company holding at least one percent of the voting power of the company may nominate a currently serving external director for an additional three year term. Israeli law does not require the adoption of and our board has not adopted a formal written charter or board resolution addressing the nomination process and related matters. Compensation of our directors and other officers of the Company is determined in accordance with Israeli law.
|
|
|
·
|
Our audit committee has not adopted a formal written audit committee charter specifying the items enumerated in NASDAQ Listing Rule 5605(c)(1). We believe that the members of our audit committee comply with the requirements of the Israeli law, as well as NASDAQ Listing Rule 5605(c)(3) and Rule 10A-3(b) of the general rules and regulations promulgated under the Securities Act of 1933. For a detailed discussion please refer to "Item 6. Directors, Senior Management and Employees- Audit Committee".
|
|
|
·
|
As opposed to NASDAQ Listing Rule 5620(c)(3), which sets forth a minimum quorum for a shareholders meeting, under Israeli law a company is entitled to determine in its articles of association the number of shareholders and percentage of holdings required for a quorum at a shareholders meeting. Our current articles of association provide that a quorum of two or more shareholders, present in person or by proxy, holding shares conferring in the aggregate more than thirty three and a third (33 1/3 %) percent of the voting power of the Company is required.
|
|
|
·
|
All related party transactions are approved in accordance with the requirements and procedures for approval of interested party acts and transactions set forth in the Israeli Companies Law-1999, and are not subject to the review process set forth in NASDAQ Listing Rule 5630. For a detailed discussion please refer to "Item 10. Additional Information- the Israeli Companies Law-1999".
|
|
|
·
|
We seek shareholder approval for all corporate action requiring such approval in accordance with the requirements of the Israeli Companies Law – 1999 rather than under the requirements of the NASDAQ Marketplace Rules, including (but not limited to) the appointment or termination of auditors, appointment and dismissal of directors, approval of interested party acts and transactions requiring general meeting approval as discussed above and a merger.
|
|
|
·
|
We follow the provisions of the Israeli Companies Law with respect to matters in connection with the composition and responsibilities of our compensation committee, office holder compensation, and any required approval by the shareholders of such compensation. Israeli law, and our amended and restated articles of association, do not require that a compensation committee composed solely of independent members of our board of directors determine (or recommend to the board of directors for determination) an executive officer’s compensation, as required under NASDAQ’s recently adopted listing standards related to compensation committee independence and responsibilities; nor do they require that the Company adopt and file a compensation committee charter. Instead, our compensation committee has been established and conducts itself in accordance with provisions governing the composition of and the responsibilities of a compensation committee as set forth in the Israeli Companies Law. Furthermore, the compensation of office holders is determined and approved by our compensation committee and our board of directors, and in certain circumstances by our shareholders, either in consistency with our previously approved Executive Compensation Policy or, in special circumstances in deviation therefrom, taking into account certain considerations set forth in the Israeli Companies Law. The requirements for approval by the shareholders for any office holder compensation, and the relevant majority or special majority for such approval, are all as set forth in the Israeli Companies Law. Thus, we will seek shareholder approval for all corporate actions with respect to office holder compensation requiring such approval under the requirements of the Israeli Companies Law, including seeking prior approval of the shareholders for the Executive Compensation Policy and for certain office holder compensation, rather than seeking approval for such corporate actions in accordance with NASDAQ Listing Rules.
|
|
|
·
|
We do not necessarily seek shareholder approval for the establishment of, and amendments to, stock option or equity compensation plans (as set forth in NASDAQ Listing Rule 5635(c)), as such matters are not subject to shareholder approval under Israeli law. We will attempt to seek shareholder approval for our stock option or equity compensation plans (and the relevant annexes thereto) to the extent required in order to ensure they are tax qualified for our employees in the United States. However, if such approval is not received, then the stock option or equity compensation plans will continue to be in effect, but the Company will be unable to grant options to its U.S. employees that qualify as Incentive Stock Options for U.S. federal tax purpose. Our stock option or other equity compensation plans are also available to our non-U.S. employees, and provide features necessary to comply with applicable non-U.S. tax laws.
|
|
1.1
|
Amended and Restated Articles of Association, adopted on January 24, 2008, filed by us as an Exhibit to our registration statement on Form S-8, as filed with the Securities and Exchange Commission on February 11, 2008, and incorporated herein by reference.
|
|
1.2
|
Amendment to Articles of Association of the Registrant incorporated by reference to Proposal 5 found in Exhibit 2 to the Form 6-K as filed with the Securities and Exchange Commission on March 1, 2012, and incorporated herein by reference.
|
|
4.1
|
Lease between the Company and Yaakov Metzkin and Dov Segev, for premises in Kfar Sava, Israel, dated November 1, 1994, and amendment dated March 17, 2002, filed by us as an Exhibit to our annual report on Form 20-F for the fiscal year ended December 31, 2001, as filed with the Securities and Exchange Commission on June 27, 2002, and incorporated herein by reference. As this lease and the amendment are written in Hebrew, a summary of each was included in the Exhibit.
|
|
4.2
|
Lease between the Company and Naji Yechezkel Yokenam Industrial Center Ltd. for manufacturing facility in Yokneam, Israel, dated November 20, 2008 filed by us as an Exhibit to our annual report on Form 20-F for the fiscal year ended December 31, 2008, as filed with the Securities and Exchange Commission on March 23, 2009, and incorporated herein by reference. As this lease is written in Hebrew, a summary was included in the Exhibit.
|
|
4.3
|
Sublease Agreement Lease between the Company and Lumenis Ltd. for the site of our manufacturing facility in Yokneam, Israel, dated August 1, 2013, and an amendment dated November 21, 2013. As this sublease agreement and the amendment are written in Hebrew, a summary is being filed by us as an exhibit to this annual report on Form 20-F for the fiscal year ended December 31, 2013, as filed with the Securities and Exchange Commission.
|
|
4.4
|
Lease between Silicom Connectivity Solutions, Inc. and RAD Data Communications Inc., for space in Mahwah, New Jersey, dated as of September 1, 1997, filed by us as an Exhibit to our annual report on Form 20-F for the fiscal year ended December 31, 2000, as filed with the Securities and Exchange Commission on June 30, 2001, and incorporated herein by reference.
|
|
4.5
|
Sublease Agreement between Silicom Connectivity Solutions, Inc. and Radcom Equipmet, Inc., for space in Paramus, New Jersey, dated as of February 1, 2004, filed by us as an Exhibit to our annual report on Form 20-F for the fiscal year ended December 31, 2003, as filed with the Securities and Exchange Commission on June 30, 2004, and incorporated herein by reference.
|
|
4.6
|
The Executive Compensation Policy of the Registrant approved by the Shareholders on July 31, 2013, filed by us as Annex A to Proposal 1 found in Exhibit 2 to the Form 6-K as filed with the Securities and Exchange Commission on June 26, 2013, and incorporated herein by reference.
|
|
8.
|
List of subsidiaries, filed by us as an Exhibit to our annual report on Form 20-F for the fiscal year ended December 31, 2000, as filed with the Securities and Exchange Commission on June 30, 2001, and incorporated herein by reference.
|
|
11.1
|
Code of Ethics, filed by us as an Exhibit to our annual report on Form 20-F for the fiscal year ended December 31, 2007, as filed with the Securities and Exchange Commission on March 26, 2008, and incorporated herein by reference.
|
|
12.1
|
Certification by Chief Executive Officer pursuant to section 302 of the Sarbanes-Oxley Act of 2002.
|
|
12.2
|
Certification by Chief Financial Officer pursuant to section 302 of the Sarbanes-Oxley Act of 2002.
|
|
13.1
|
Certification by Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
|
13.2
|
Certification by Chief Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
|
|
|
15.1
|
Consent of Somekh Chaikin, Independent Registered Public Accounting Firm, a member firm of KPMG International.
|
|
SILICOM LIMITED
|
|||
| By: |
/S/ Shaike Orbach
|
||
|
Shaike Orbach
|
|||
|
Chief Executive Officer
|
|||
|
Page
|
|
|
F - 1
|
|
|
F - 3
|
|
|
F - 5
|
|
|
F - 6
|
|
|
F - 7
|
|
|
F - 8
|
|
|
|
2012
|
2013
|
||||||||
|
|
Note
|
US$ thousands
|
US$ thousands
|
||||||||
|
|
|
|
|
||||||||
|
Assets
|
|
|
|
||||||||
|
|
|
|
|
||||||||
|
Current assets
|
|
|
|
||||||||
|
Cash and cash equivalents
|
3 | 13,306 | 12,997 | ||||||||
|
Short-term bank deposits
|
2E | 2,527 | 3,000 | ||||||||
|
Marketable securities
|
2F, 4 | 12,583 | 14,871 | ||||||||
|
Accounts receivable:
|
|||||||||||
|
Trade, net
|
2G | 12,146 | 14,482 | ||||||||
|
Other
|
2,234 | 2,460 | |||||||||
|
Related parties
|
245 | 384 | |||||||||
|
Inventories
|
5 | 14,795 | 28,778 | ||||||||
|
Deferred tax assets
|
12H | 47 | 274 | ||||||||
|
|
|||||||||||
|
Total current assets
|
57,883 | 77,246 | |||||||||
|
|
|||||||||||
|
Marketable securities
|
2F, 4 | 28,469 | 24,370 | ||||||||
|
|
|||||||||||
|
Assets held for employees' severance benefits
|
7 | 1,377 | 1,543 | ||||||||
|
|
|||||||||||
|
Deferred tax assets
|
12H | 114 | 439 | ||||||||
|
|
|||||||||||
|
Property, plant and equipment ("PPE"), net
|
6 | 1,190 | 1,479 | ||||||||
|
|
|||||||||||
|
Intangible assets, net
|
- | 180 | |||||||||
|
|
|||||||||||
|
Total assets
|
89,033 | 105,257 | |||||||||
|
Avi Eizenman
|
Shaike Orbach
|
Eran Gilad
|
||
|
Chairman of the Board of Directors
|
Chief Executive Officer
|
Chief Financial Officer
|
|
|
|
2012
|
2013
|
||||||||
|
|
Note
|
US$ thousands
|
US$ thousands
|
||||||||
|
|
|
|
|
||||||||
|
|
|
|
|
||||||||
|
Liabilities and shareholders' equity
|
|
|
|
||||||||
|
|
|
|
|
||||||||
|
Current liabilities
|
|
|
|
||||||||
|
Trade accounts payable
|
|
7,799 | 6,764 | ||||||||
|
Other accounts payable and accrued expenses
|
|
3,914 | 5,134 | ||||||||
|
Related parties
|
|
76 | 50 | ||||||||
|
|
|
||||||||||
|
Total current liabilities
|
|
11,789 | 11,948 | ||||||||
|
|
|
||||||||||
|
Long-term liability
|
|
||||||||||
|
Liability for employees' severance benefits
|
7 | 2,278 | 2,618 | ||||||||
|
|
|||||||||||
|
Total liabilities
|
14,067 | 14,566 | |||||||||
|
|
|||||||||||
|
Commitments and contingencies
|
8 | ||||||||||
|
|
|||||||||||
|
|
|||||||||||
|
Shareholders' equity
|
9 | ||||||||||
|
Ordinary shares, NIS 0.01 par value; 10,000,000 shares
|
|||||||||||
|
authorized; 7,022,397 and 7,154,984 issued as at
|
|||||||||||
|
December 31, 2012 and 2013, respectively;
|
|||||||||||
|
7,007,426 and 7,140,013 outstanding as at
|
|||||||||||
|
December 31, 2012 and 2013, respectively
|
21 | 21 | |||||||||
|
Additional paid-in capital
|
36,065 | 38,626 | |||||||||
|
Treasury shares (at cost) - 14,971 ordinary shares as at
|
|||||||||||
|
December 31, 2012 and 2013
|
(38 | ) | (38 | ) | |||||||
|
Retained earnings
|
38,918 | 52,082 | |||||||||
|
Total shareholders' equity
|
74,966 | 90,691 | |||||||||
|
|
|||||||||||
|
Total liabilities and shareholders’ equity
|
89,033 | 105,257 | |||||||||
|
|
|
2011
|
2012
|
2013
|
|||||||||||
|
|
|
US$ thousands
|
|||||||||||||
|
|
Note
|
Except for share and per share data
|
|||||||||||||
|
|
|
|
|
|
|||||||||||
|
Sales*
|
10 | 39,633 | 48,729 | 73,298 | |||||||||||
|
Cost of sales
|
22,430 | 28,849 | 43,865 | ||||||||||||
|
|
|||||||||||||||
|
Gross profit
|
17,203 | 19,880 | 29,433 | ||||||||||||
|
|
|||||||||||||||
|
Operating expenses
|
|||||||||||||||
|
Research and development**
|
4,165 | 4,401 | 5,465 | ||||||||||||
|
Sales and marketing
|
2,677 | 3,081 | 3,818 | ||||||||||||
|
General and administrative
|
1,890 | 2,369 | 2,572 | ||||||||||||
|
|
|||||||||||||||
|
Total operating expenses
|
8,732 | 9,851 | 11,855 | ||||||||||||
|
|
|||||||||||||||
|
Operating income
|
8,471 | 10,029 | 17,578 | ||||||||||||
|
Financial income, net
|
11 | 439 | 752 | 404 | |||||||||||
|
|
|||||||||||||||
|
Income before income taxes
|
8,910 | 10,781 | 17,982 | ||||||||||||
|
|
|||||||||||||||
|
Income taxes
|
12 | 667 | 910 | 905 | |||||||||||
|
|
|||||||||||||||
|
Net income
|
8,243 | 9,871 | 17,077 | ||||||||||||
|
|
|||||||||||||||
|
Income per share:
|
|||||||||||||||
|
Basic income per ordinary share (US$)
|
2T | 1.195 | 1.424 | 2.404 | |||||||||||
|
|
|||||||||||||||
|
Diluted income per ordinary share (US$)
|
1.178 | 1.417 | 2.357 | ||||||||||||
|
|
|||||||||||||||
|
Weighted average number of ordinary
|
|||||||||||||||
|
shares used to compute basic income
|
|||||||||||||||
|
per share (in thousands)
|
6,896 | 6,934 | 7,103 | ||||||||||||
|
|
|||||||||||||||
|
Weighted average number of ordinary
|
|||||||||||||||
|
shares used to compute diluted income
|
|||||||||||||||
|
per share (in thousands)
|
6,995 | 6,968 | 7,246 | ||||||||||||
|
|
Ordinary shares
|
Additional paid-in capital
|
Treasury shares
|
Retained earnings
|
Total shareholders’ Equity
|
|||||||||||||||||||
|
|
Number
of shares
(1)
|
US$ thousands
|
||||||||||||||||||||||
|
|
|
|
|
|
|
|
||||||||||||||||||
|
Balance at
|
|
|
|
|
|
|
||||||||||||||||||
|
January 1, 2011
|
6,879,688 | 20 | 34,644 | (38 | ) | 20,804 | 55,430 | |||||||||||||||||
|
|
||||||||||||||||||||||||
|
Exercise of options
|
45,400 | *- | 164 | - | - | 164 | ||||||||||||||||||
|
Share-based compensation
|
- | - | 437 | - | - | 437 | ||||||||||||||||||
|
Net income
|
- | - | - | - | 8,243 | 8,243 | ||||||||||||||||||
|
|
||||||||||||||||||||||||
|
Balance at
|
||||||||||||||||||||||||
|
December 31, 2011
|
6,925,088 | 20 | 35,245 | (38 | ) | 29,047 | 64,274 | |||||||||||||||||
|
|
||||||||||||||||||||||||
|
Exercise of options
|
82,338 | 1 | 276 | - | - | 277 | ||||||||||||||||||
|
Share-based compensation
|
- | - | 544 | - | - | 544 | ||||||||||||||||||
|
Net income
|
- | - | - | - | 9,871 | 9,871 | ||||||||||||||||||
|
|
||||||||||||||||||||||||
|
Balance at
|
||||||||||||||||||||||||
|
December 31, 2012
|
7,007,426 | 21 | 36,065 | (38 | ) | 38,918 | 74,966 | |||||||||||||||||
|
|
||||||||||||||||||||||||
|
Exercise of options
|
132,587 | *- | 1,893 | - | - | 1,893 | ||||||||||||||||||
|
Share-based compensation
|
- | - | 668 | - | - | 668 | ||||||||||||||||||
|
Dividend
|
- | - | - | - | (3,913 | ) | (3,913 | ) | ||||||||||||||||
|
Net income
|
- | - | - | - | 17,077 | 17,077 | ||||||||||||||||||
|
|
||||||||||||||||||||||||
|
Balance at
|
||||||||||||||||||||||||
|
December 31, 2013
|
7,140,013 | 21 | 38,626 | (38 | ) | 52,082 | 90,691 | |||||||||||||||||
|
(1)
|
Net of 14,971 shares held by the subsidiary
|
|
*
|
Less than 1 thousand.
|
|
|
2011
|
2012
|
2013
|
|||||||||
|
|
US$ thousands
|
|||||||||||
|
Cash flows from operating activities
|
|
|
|
|||||||||
|
Net income
|
8,243 | 9,871 | 17,077 | |||||||||
|
|
||||||||||||
|
Adjustments required to reconcile net income to
|
||||||||||||
|
net cash provided by operating activities:
|
||||||||||||
|
Depreciation and amortization
|
379 | 454 | 659 | |||||||||
|
Write-down of obsolete inventory
|
768 | 873 | 1,926 | |||||||||
|
Liability for employees' severance benefits, net
|
(42 | ) | 23 | 174 | ||||||||
|
Discount of marketable securities
|
462 | 579 | 729 | |||||||||
|
Share-based compensation expense
|
437 | 544 | 668 | |||||||||
|
Deferred taxes
|
86 | 22 | (552 | ) | ||||||||
|
Capital (gain) loss
|
(6 | ) | - | 1 | ||||||||
|
Changes in assets and liabilities:
|
||||||||||||
|
Accounts receivable - trade
|
(1,780 | ) | (3,741 | ) | (2,322 | ) | ||||||
|
Accounts receivable - other
|
(717 | ) | (537 | ) | (114 | ) | ||||||
|
Accounts receivable - Related parties
|
(71 | ) | (37 | ) | (139 | ) | ||||||
|
Inventories
|
(3,801 | ) | (4,495 | ) | (15,909 | ) | ||||||
|
Trade accounts payable
|
250 | 3,828 | (1,474 | ) | ||||||||
|
Other accounts payable and accrued expenses
|
508 | 1,436 | 1,220 | |||||||||
|
Accounts payable - Related parties
|
(25 | ) | 69 | (26 | ) | |||||||
|
Net cash provided by operating activities
|
4,691 | 8,889 | 1,918 | |||||||||
|
|
||||||||||||
|
Cash flows from investing activities
|
||||||||||||
|
Proceeds from (investments in) short term bank deposits, net
|
4,199 | 2,483 | (473 | ) | ||||||||
|
Purchases of property, plant and equipment
|
(486 | ) | (798 | ) | (822 | ) | ||||||
|
Investment in intangible assets
|
- | - | (100 | ) | ||||||||
|
Proceeds from maturity of marketable securities
|
9,531 | 8,955 | 12,500 | |||||||||
|
Purchases of marketable securities
|
(13,071 | ) | (17,992 | ) | (11,384 | ) | ||||||
|
Net cash provided by (used in) investing activities
|
173 | (7,352 | ) | (279 | ) | |||||||
|
|
||||||||||||
|
Cash flows from financing activities
|
||||||||||||
|
Exercise of options
|
164 | 277 | 1,893 | |||||||||
|
Dividend
|
- | - | (3,913 | ) | ||||||||
|
Net cash provided by (used in) financing activities
|
164 | 277 | (2,020 | ) | ||||||||
|
|
||||||||||||
|
Effect of exchange rate changes on cash balances held
|
(202 | ) | 9 | 72 | ||||||||
|
|
||||||||||||
|
Increase (decrease) in cash and cash equivalents
|
4,826 | 1,823 | (309 | ) | ||||||||
|
|
||||||||||||
|
Cash and cash equivalents at beginning of year
|
6,657 | 11,483 | 13,306 | |||||||||
|
Cash and cash equivalents at end of year
|
11,483 | 13,306 | 12,997 | |||||||||
|
|
||||||||||||
|
Supplementary cash flow information
|
||||||||||||
|
A. Non-cash transactions:
|
||||||||||||
|
Investments in PPE and Intangible assets
|
80 | 9 | 207 | |||||||||
|
B. Cash paid during the year for:
|
||||||||||||
|
Income taxes
|
623 | 635 | 2,154 | |||||||||
|
|
A.
|
Financial statements in US dollars
|
|
|
B.
|
Basis of presentation
|
|
|
C.
|
Estimates and assumptions
|
|
|
D.
|
Cash and cash equivalents
|
|
|
E.
|
Short-term bank deposits
|
|
|
F.
|
Marketable securities
|
|
|
F.
|
Marketable securities
(
cont’d
)
|
|
|
G.
|
Trade accounts receivable, net
|
|
|
H.
|
Inventories
|
|
|
I.
|
Assets held for employees’ severance benefits
|
|
|
J.
|
Property, plant and equipment
|
|
%
|
||
|
Machinery and equipment
|
15 - 33
|
|
|
Office furniture and equipment
|
6 - 33
|
|
|
Leasehold improvements
|
10- 20
|
|
|
|
K.
|
Intangible assets
|
|
|
L.
|
Long lived assets
|
|
|
M.
|
Revenue recognition
|
|
|
N.
|
Research and development costs
|
|
|
O.
|
Royalty bearing participations
|
|
|
P.
|
Allowance for product warranty
|
|
|
Q.
|
Treasury shares
|
|
|
R.
|
Income taxes
|
|
|
S.
|
Share-based compensation
|
|
|
T.
|
Basic and diluted earnings per share
|
|
|
Year ended December 31
|
|||||||||||
|
|
2011
|
2012
|
2013
|
|||||||||
|
Net income attributable to ordinary shares
|
|
|
|
|||||||||
|
(US$ thousands)
|
8,243 | 9,871 | 17,077 | |||||||||
|
|
||||||||||||
|
Weighted average number of ordinary shares outstanding
|
||||||||||||
|
used in basic income per ordinary share calculation
|
6,896,215 | 6,933,576 | 7,103,021 | |||||||||
|
|
||||||||||||
|
Add assumed exercise of outstanding dilutive potential
|
||||||||||||
|
ordinary shares
|
98,377 | 34,729 | 143,011 | |||||||||
|
|
||||||||||||
|
Weighted average number of ordinary shares outstanding
|
||||||||||||
|
used in diluted income per ordinary share calculation
|
6,994,592 | 6,968,305 | 7,246,032 | |||||||||
|
|
||||||||||||
|
Basic income per ordinary shares (US$)
|
1.195 | 1.424 | 2.404 | |||||||||
|
|
||||||||||||
|
Diluted income per ordinary shares (US$)
|
1.178 | 1.417 | 2.357 | |||||||||
|
|
||||||||||||
|
Number of options and warrants excluded
|
||||||||||||
|
from the diluted earnings per share calculation
|
||||||||||||
|
because of anti-dilutive effect
|
135,000 | 135,000 | - | |||||||||
|
|
U.
|
Comprehensive Income
|
|
|
V.
|
Fair Value Measurements
|
|
|
V.
|
Fair Value Measurements (cont’d)
|
|
|
W.
|
Concentrations of risks
|
|
(1)
|
Credit risk
|
|
|
W.
|
Concentrations of risks (cont’d)
|
|
(2)
|
Dominant customers
|
|
|
X.
|
Liabilities for loss contingencies
|
|
|
December 31
|
|||||||
|
|
2012
|
2013
|
||||||
|
|
US$ thousands
|
|||||||
|
|
|
|
||||||
|
Cash
|
13,248 | 10,593 | ||||||
|
Cash equivalents *
|
58 | 2,404 | ||||||
|
|
13,306 | 12,997 | ||||||
|
|
|
Gross
|
Gross
|
|
||||||||||||
|
|
|
unrealized
|
unrealized
|
|
||||||||||||
|
|
Amortized
|
holding
|
holding
|
Aggregate
|
||||||||||||
|
|
cost basis**
|
gains
|
(losses)
|
fair value*
|
||||||||||||
|
|
US$ thousands
|
|||||||||||||||
|
At December 31, 2013
|
|
|
|
|
||||||||||||
|
Held to maturity:
|
|
|
|
|
||||||||||||
|
Corporate debt securities and
|
|
|
|
|
||||||||||||
|
government debt securities
|
|
|
|
|
||||||||||||
|
Current
|
15,015 | 20 | (76 | ) | 14,959 | |||||||||||
|
Non-Current
|
24,617 | 69 | (167 | ) | 24,519 | |||||||||||
|
|
||||||||||||||||
|
|
39,632 | 89 | (243 | ) | 39,478 | |||||||||||
|
|
||||||||||||||||
|
At December 31, 2012
|
||||||||||||||||
|
Held to maturity:
|
||||||||||||||||
|
Corporate debt securities and
|
||||||||||||||||
|
government debt securities
|
||||||||||||||||
|
Current
|
12,702 | 23 | (56 | ) | 12,669 | |||||||||||
|
Non-Current
|
28,775 | 193 | (126 | ) | 28,842 | |||||||||||
|
|
||||||||||||||||
|
|
41,477 | 216 | (182 | ) | 41,511 | |||||||||||
|
*
|
Fair value is being determined using quoted market prices in active markets (Level 1).
|
|||||||
|
**
|
Including accrued interest in the amount of $425K and $391K as of December 31, 2012 and 2013 respectively.
|
|||||||
|
|
December 31, 2013
|
|||||||||||
|
|
|
Net unrealized
|
|
|||||||||
|
|
|
holding
|
|
|||||||||
|
|
Amortized cost
|
gains/(losses)
|
Fair value
|
|||||||||
|
|
US$ thousands
|
|||||||||||
|
|
|
|
|
|||||||||
|
Up to 2%
|
34,945 | (217 | ) | 34,728 | ||||||||
|
2.05% - 2.951%
|
4,687 | 63 | 4,750 | |||||||||
|
|
39,632 | (154 | ) | 39,478 | ||||||||
|
|
December 31, 2012
|
|||||||||||
|
|
|
Net unrealized
|
|
|||||||||
|
|
|
holding
|
|
|||||||||
|
|
Amortized cost
|
gains/(losses)
|
Fair value
|
|||||||||
|
|
US$ thousands
|
|||||||||||
|
|
|
|
|
|||||||||
|
Up to 2%
|
33,145 | (84 | ) | 33,061 | ||||||||
|
2.038% - 2.951%
|
8,332 | 118 | 8,450 | |||||||||
|
|
41,477 | 34 | 41,511 | |||||||||
|
Activity in marketable securities in 2013
|
US$ thousands
|
|||
|
|
|
|||
|
Balance at January 1, 2013
|
41,477 | |||
|
|
||||
|
Purchases of marketable securities
|
11,384 | |||
|
Discount of marketable securities
|
(729 | ) | ||
|
Proceeds from maturity of marketable securities
|
(12,500 | ) | ||
|
Balance at December 31, 2013
|
39,632 | |||
|
Less than 12 months
|
12 months or more
|
Total
|
||||||||||||||||||||||
|
Held to maturity
|
Unrealized Losses
|
Fair value
|
Unrealized Losses
|
Fair value
|
Unrealized Losses
|
Fair value
|
||||||||||||||||||
|
|
|
|
|
|
|
|
||||||||||||||||||
|
Corporate debt securities
|
|
|
|
|
|
|
||||||||||||||||||
|
and government debt
|
|
|
|
|
|
|
||||||||||||||||||
|
securities
|
(144 | ) | 19,313 | (99 | ) | 8,112 | (243 | ) | 27,425 | |||||||||||||||
|
|
December 31
|
|||||||
|
|
2012
|
2013
|
||||||
|
|
US$ thousands
|
|||||||
|
|
|
|
||||||
|
Raw materials and components
|
5,971 | 9,041 | ||||||
|
Products in process
|
6,908 | 13,081 | ||||||
|
Finished products
|
1,916 | 6,656 | ||||||
|
|
14,795 | 28,778 | ||||||
|
|
December 31
|
|||||||
|
|
2012
|
2013
|
||||||
|
|
US$ thousands
|
|||||||
|
|
|
|
||||||
|
Machinery and equipment
|
3,240 | 4,028 | ||||||
|
Office furniture and equipment
|
294 | 389 | ||||||
|
Leasehold improvements
|
441 | 486 | ||||||
|
|
||||||||
|
Property, plant and equipment
|
3,975 | 4,903 | ||||||
|
|
||||||||
|
Accumulated depreciation
|
(2,785 | ) | (3,424 | ) | ||||
|
|
||||||||
|
Property, Plant and equipment, net
|
1,190 | 1,479 | ||||||
|
|
A.
|
Under Israeli law and labor agreements, Silicom is required to make severance payments to retired or dismissed employees and to employees leaving employment in certain other circumstances.
|
|
|
B.
|
According to Section 14 to the Severance Pay Law ("Section 14") the payment of monthly deposits by a company into recognized severance and pension funds or insurance policies releases it from any additional severance obligation to the employees that have entered into agreements with the company pursuant to such Section 14. Commencing July 1, 2008, the Company has entered into agreements with a majority of its employees in order to implement Section 14. Therefore, as of that date, the payment of monthly deposits by the Company into recognized severance and pension funds or insurance policies releases it from any additional severance obligation to those employees that have entered into such agreements and therefore the Company incurs no additional liability since that date with respect to such employees. Amounts accumulated in the pension funds or insurance policies pursuant to Section 14 are not supervised or administrated by the Company and therefore neither such amounts nor the corresponding accrual are reflected in the balance sheet.
|
|
|
C.
|
Consequently, the assets held for employees' severance benefits reported on the balance sheet, in respect of deposits for those employees who have signed agreements pursuant to Section 14, represent the redemption value of deposits made through June 30, 2008. The liability for employee severance benefits, with respect to those employees, represents the liability of the Company for employees' severance benefits as of June 30, 2008.
|
|
|
D.
|
Expenses recorded with respect to employees' severance payments for the years ended December 31, 2011, 2012 and 2013 were US$ 304 thousand, US$ 382 thousand and US$ 578 thousand, respectively.
|
|
|
A.
|
Royalty commitments
|
|
B.
|
Lease commitments
|
|
|
The premises and facilities occupied by the Company are leased under various operating lease agreements. Furthermore, the Company has entered into several operating lease agreements for motor vehicles in Israel.
|
|
|
US$ thousands
|
|||
|
Year ended December 31
|
|
|||
|
2014
|
944 | |||
|
2015
|
634 | |||
|
2016 and on
|
491 | |||
|
|
A.
|
On July 21, 2004, the Board resolved, subject to shareholders’ approval that was given on December 30, 2004, to adopt the Share Option Plan (2004) (the "2004 Plan"). Option grants to employees under the 2004 Plan, including terms of vesting and the exercise price, are subject to the Board of Directors' approval. Option grants to directors and certain other officers are generally subject to the approvals of the Compensation Committee as well as Board of Directors, and grants to directors or a CEO will also generally have to be approved by the Shareholders. The term of the options shall not exceed 10 years from the date that the option was granted.
The 2004 plan initially covered up to 282,750 options and subsequent to an amendment by the board in 2007 it covered up to 582,750 options. In August 2012, the Board of Directors increased the number of the ordinary shares available for issuance under the 2004 plan by an additional 500,000. All options are at a conversion rate of 1:1.
On October 21, 2013 the Board resolved to adopt the Global Share Incentive Plan (2013) (the "2013 plan") and to reserve up to 500,000 ordinary shares for issuance under the Plan to employees, directors, officers and consultants of the Company or of any subsidiary or affiliate of the Company. Grants under the 2013 Plan, whether as options, restricted stock units, restricted stock or other equity based awards, including their terms, are subject to the Board of Directors' approval. Grants to directors and certain other officers are generally subject to the approvals of the Compensation Committee as well as Board of Directors, and grants to directors or a CEO (and under certain circumstances certain other officers) will also have to be approved by the Shareholders.
|
|
|
B.
|
No options have been granted by the Company other than to employees and directors, as mentioned above.
|
|
|
C.
|
Options granted to Israeli residents may be granted under Section 102 of the Israeli Income Tax Ordinance pursuant to which the awards of options, or the ordinary shares issued upon their exercise, must be deposited with a trustee for at least two years following the date of grant. Under Section 102, any tax payable by an employee from the grant or exercise of the awards is deferred until the transfer of the awards or ordinary shares by the trustee to the employee or upon the sale of the awards or ordinary shares.
Gains on awards granted under the plans are subjected to capital gains tax of 25% to be paid by the employee, and the Company is not entitled to a tax deduction.
|
|
|
D.
|
On October 15, 2008, the Company granted, in the aggregate, 200,000 options to certain of its directors and employees under the 2004 Plan. In relation to this grant:
|
|
|
1.
|
The exercise price for the options (per ordinary share) was US$ 3.82 and the option expiration date was the earlier to occur of: (a) October 15, 2016; and (b) the closing price of the shares falling below US$ 1.91 at any time after the date of grant. 50% of the options vest and become exercisable on the second anniversary of the date of grant and the additional 50% of the options vest and become exercisable on the third anniversary of the date of the grant.
|
|
|
2.
|
The Company recognizes compensation expenses on these options based on estimated grant date fair value using the Monte Carlo option-pricing model with the following assumptions:
|
|
Average Risk-free interest rate
(a)
|
3.73%
|
|
Expected dividend yield
|
0.0%
|
|
Average expected volatility
(b)
|
112.42%
|
|
Termination rate
|
11%
|
|
Suboptimal rate
(c)
|
3.45
|
|
(a)
|
Risk-free interest rate represents risk free US$ zero-coupon US Government Bonds at time of grant.
|
|
|
(b)
|
Expected average volatility represents a weighted average standard deviation rate for the price of the Company’s ordinary shares on the NASDAQ National Market.
|
|
|
(c)
|
Suboptimal rate represents the multiple of the increase in the market share price on the day of grant of the option which, should it come to pass, will lead to exercise of the option by the employee. It is the average suboptimal rate of the Company and similar companies.
|
|
|
3.
|
No expenses were incurred during the year ended December 31, 2013 in relation to this grant. As at December 31, 2013, all expenses related to this grant were recognized.
|
|
|
E.
|
On December 21, 2010, the Company granted, in the aggregate, 137,500 options to certain of its directors and employees under the 2004 Plan. In relation to this grant:
|
|
|
1.
|
The exercise price for the options (per ordinary share) was US$ 18.82 and the Option expiration date was the earlier to occur of: (a) December 21, 2018; and (b) the closing price of the shares falling below US$ 9.41 at any time after the date of grant. 50% of the options vest and become exercisable on the second anniversary of the date of grant and the additional 50% of the options vest and become exercisable on the third anniversary of the date of the grant.
|
|
|
2.
|
The Company recognizes compensation expenses on these options based on estimated grant date fair value using the Binomial option-pricing model with the following assumptions:
|
|
Average Risk-free interest rate
(a)
|
3.00%
|
|
Expected dividend yield
|
0.0%
|
|
Average expected volatility
(b)
|
82.64%
|
|
Termination rate
|
9%
|
|
Suboptimal rate
(c)
|
3.45
|
|
(a)
|
Risk-free interest rate represents risk free US$ zero-coupon US Government Bonds at time of grant.
|
|
|
(b)
|
Expected average volatility represents a weighted average standard deviation rate for the price of the Company’s ordinary shares on the NASDAQ National Market.
|
|
|
(c)
|
Suboptimal rate represents the multiple of the increase in the market share price on the day of grant of the option which, should it come to pass, will lead to exercise of the option by the employee. It is the average suboptimal rate of the Company and similar companies.
|
|
|
3.
|
Compensation expenses incurred during the year ended December 31, 2013 in relation to this grant were approximately US$ 149 thousand. As at December 31, 2013, all expenses related to this grant were recognized.
|
|
|
F.
|
On September 13, 2012, the Company granted, in the aggregate, 240,000 options to certain of its directors and employees under the 2004 Plan. In relation to this grant:
|
|
|
1.
|
The exercise price for the options (per ordinary share) was US$ 15.28 and the Option expiration date was the earlier to occur of: (a) September 13, 2020; and (b) the closing price of the shares falling below US$ 7.64 at any time after the date of grant. 50% of the options vest and become exercisable on the second anniversary of the date of grant and the additional 50% of the options vest and become exercisable on the third anniversary of the date of the grant.
|
|
|
2.
|
The Company recognizes compensation expenses on these options based on estimated grant date fair value using the Binomial option-pricing model with the following assumptions:
|
|
Average Risk-free interest rate
(a)
|
1.33 %
|
|
Expected dividend yield
|
0.0%
|
|
Average expected volatility
(b)
|
64.71 %
|
|
Termination rate
|
9%
|
|
Suboptimal rate
(c)
|
3.2
|
|
(a)
|
Risk-free interest rate represents risk free US$ zero-coupon US Government Bonds at time of grant.
|
|
|
(b)
|
Expected average volatility represents a weighted average standard deviation rate for the price of the Company’s ordinary shares on the NASDAQ National Market.
|
|
|
(c)
|
Suboptimal rate represents the multiple of the increase in the market share price on the day of grant of the option which, should it come to pass, will lead to exercise of the option by the employee. It is the average suboptimal rate of the Company and similar companies.
|
|
|
3.
|
Compensation expenses incurred during the year ended December 31, 2013 in relation to this grant were approximately US$ 519 thousand. As at December 31, 2013, there was approximately US$ 566 thousand of unrecognized compensation costs related to this grant to be recognized over a weighted average period of 1.19 years.
|
|
G.
|
The following table summarizes information regarding stock options as at December 31, 2013:
|
|
|
Options outstanding
|
Options exercisable
|
||||||||||||||
|
|
|
Weighted average
|
|
Weighted average
|
||||||||||||
|
|
|
remaining
|
|
remaining
|
||||||||||||
|
Exercise price
|
Number
|
contractual life
|
Number
|
contractual life
|
||||||||||||
|
US$
|
of options
|
(in years)
|
of options
|
(in years)
|
||||||||||||
|
|
|
|
|
|
||||||||||||
|
18.82
|
42,500 | 4.97 | 42,500 | 4.97 | ||||||||||||
|
15.28
|
230,250 | 6.70 | - | - | ||||||||||||
|
|
||||||||||||||||
|
|
272,750 | 42,500 | ||||||||||||||
|
H.
|
The stock option activity under the abovementioned plans is as follows:
|
|
|
|
|
Weighted
|
|||||||||
|
|
|
Weighted
|
average
|
|||||||||
|
|
Number
|
average
|
grant date
|
|||||||||
|
|
of options
|
exercise price
|
fair value
|
|||||||||
|
|
|
US$
|
US$
|
|||||||||
|
|
|
|
|
|||||||||
|
Balance at January 1, 2011
|
305,825 |
|
|
|||||||||
|
|
|
|
||||||||||
|
Exercised
|
(45,400 | ) | 3.62 | 1.75 | ||||||||
|
Forfeited
|
(3,000 | ) | 16.32 | 7.54 | ||||||||
|
|
||||||||||||
|
Balance at December 31, 2011
|
257,425 | |||||||||||
|
|
||||||||||||
|
Granted
|
240,000 | 15.28 | 6.54 | |||||||||
|
Exercised
|
(82,338 | ) | 3.35 | 1.81 | ||||||||
|
Forfeited
|
(2,000 | ) | 15.28 | 6.54 | ||||||||
|
|
||||||||||||
|
Balance at December 31, 2012
|
413,087 | |||||||||||
|
|
||||||||||||
|
Exercised
|
(132,587 | ) | 14.28 | 6.61 | ||||||||
|
Forfeited
|
(7,750 | ) | 15.28 | 6.54 | ||||||||
|
|
||||||||||||
|
Balance at December 31, 2013
|
272,750 | |||||||||||
|
Exercisable at December 31, 2013
|
42,500 | |||||||||||
|
I.
|
During 2011, 2012 and 2013, the Company recorded share-based compensation expenses. The following summarizes the allocation of the stock-based compensation expenses:
|
|
|
Year ended December 31
|
|||||||||||
|
|
2011
|
2012
|
2013
|
|||||||||
|
|
US$ thousands
|
US$ thousands
|
US$ thousands
|
|||||||||
|
|
|
|
|
|||||||||
|
Cost of sales
|
24 | 46 | 103 | |||||||||
|
Research and development costs
|
96 | 130 | 193 | |||||||||
|
Selling and marketing expenses
|
134 | 159 | 177 | |||||||||
|
General and administrative expenses
|
183 | 209 | 195 | |||||||||
|
|
||||||||||||
|
|
437 | 544 | 668 | |||||||||
|
A.
|
Information on sales by geographic distribution:
The Company has one operating segment.
Sales are attributed to geographic distribution based on the location of the customer.
|
|
|
Year ended December 31
|
|||||||||||
|
|
2011
|
2012
|
2013
|
|||||||||
|
|
US$ thousands
|
|||||||||||
|
|
|
|
|
|||||||||
|
North America
|
29,627 | 33,606 | 55,655 | |||||||||
|
Europe
|
5,174 | 7,277 | 9,257 | |||||||||
|
Rest of the world
|
4,832 | 7,846 | 8,386 | |||||||||
|
|
||||||||||||
|
|
39,633 | 48,729 | 73,298 | |||||||||
|
B.
|
Sales to single customers exceeding 10% of sales (US$ thousands):
|
|
|
Year ended December 31
|
|||||||||||
|
|
2011
|
2012
|
2013
|
|||||||||
|
|
US$ thousands
|
|||||||||||
|
|
|
|
|
|||||||||
|
Customer “A”
|
4,882 | 10,809 | 24,512 | |||||||||
|
Customer “B”
|
4,195 | 8,714 | * | |||||||||
|
*
|
Less than 10% of sales.
|
|
|
Year ended December 31
|
|||||||||||
|
|
2011
|
2012
|
2013
|
|||||||||
|
|
US$ thousands
|
|||||||||||
|
|
|
|
|
|||||||||
|
Interest income
|
1,292 | 1,360 | 1,290 | |||||||||
|
Interest expenses
|
(499 | ) | (561 | ) | (643 | ) | ||||||
|
Exchange rate differences, net
|
(231 | ) | 96 | (89 | ) | |||||||
|
Bank charges
|
(123 | ) | (143 | ) | (154 | ) | ||||||
|
|
||||||||||||
|
|
439 | 752 | 404 | |||||||||
|
|
A.
|
Measurement of results for tax purposes under the Israeli Income Tax Regulations (Rules for Maintaining Accounting Records of Foreign Invested Companies and Certain Partnerships and Determining Their Taxable Income) - 1986
|
|
|
B.
|
Israel tax reform
|
|
|
C.
|
Tax benefits under the Israeli Law for the Encouragement of Capital Investments, 1959 (hereinafter - the “Law”)
|
|
1.
|
Rates
|
|
|
a.
|
The Company has elected to be taxed under the alternative benefits method, whereby the Company waives grants in return for tax exemptions. For the manufacturing plant in Yokneam the Company is entitled to an exemption from tax on its taxable income for a period of ten years beginning from the year of election; For the research and development center the Company is entitled to an exemption from tax on its taxable income for two years beginning from the year of election, and not more than 25%, on its taxable income in the next eight years.
|
|
|
C.
|
Tax benefits under the Israeli Law for the Encouragement of Capital Investments, 1959 (hereinafter - the “Law”) (cont'd)
|
|
1.
|
Rates (cont'd)
|
|
|
b.
|
In the event of distribution by the Company of cash dividends out of its retained earnings that were tax exempt due to the “Approved Enterprise” or "Benefited Enterprise" (See Note 12C 4) status, the Company would be subjected to a maximum of 25% corporate tax on the amount distributed, and a further 15% withholding tax would be deducted from the amounts distributed to the shareholders.
|
|
|
Out of the Company’s retained earnings as of December 31, 2013 and 2012, approximately US$ 50,683 thousand and US$ 30,779 thousand are tax-exempt respectively, due to “Approved Enterprise” and "Benefited Enterprise" status. If such tax-exempt income is distributed by cash dividend (including a liquidation dividend), it would be taxed at the reduced corporate tax rate applicable to such profits (up to 25%) and an income tax liability of up to approximately US$ 12,671 thousand and US$ 7,695 thousand would be incurred as of December 31, 2013 and 2012, respectively. The Company anticipates that any future dividends distributed pursuant to its dividend policy, will be distributed from income sources which will not impose additional tax liabilities on the company. The Company intends to reinvest the amount of its tax-exempt income. Accordingly, no deferred income taxes have been provided on income attributable to the Company’s “Approved Enterprise" or "Benefited Enterprise" as the undistributed tax exempt income is essentially permanent in duration.
|
|
|
c.
|
Should the Company derive income from sources other than the “Approved Enterprise” or "Benefited Enterprise" during the relevant period of benefits, such income will be taxable at the regular corporate tax rates for the applicable year.
|
|
|
2.
|
Accelerated depreciation
|
|
|
3.
|
Conditions for entitlement to the tax benefits
|
|
|
C.
|
Tax benefits under the Israeli Law for the Encouragement of Capital Investments, 1959 (hereinafter - the “Law”) (cont'd)
|
|
|
3.
|
Conditions for entitlement to the tax benefits (cont'd)
|
|
4.
|
Amendments to the Law
|
|
|
(a)
|
Companies that meet the criteria of the “Benefited Enterprise” (formerly known as Alternative Path of “Approved Enterprise”) benefits will receive those benefits without prior approval. In addition, there will be no requirement to file reports with the Investment Center. Companies will be required to notify the Israeli Tax Authorities regarding the implementation of the “Benefited Enterprise”. Audits will take place via the Israeli Income Tax Authorities as part of the tax audits. Request for pre-ruling is possible.
|
|
|
(b)
|
Tax benefits of the “Benefited Enterprise” comparing to regular corporate tax regulations, include lower tax rates or no tax depending on the area and the path chosen, lower tax rates on dividend income and accelerated tax depreciation. The tax benefits do not differ from those prior the amendment.
|
|
|
(c)
|
In order to receive the tax benefits in the Grant Path or the “Benefited Enterprise”, the “Industrial Company” must contribute to the economic independence of Israel’s economy in one of the following ways:
|
|
|
1.
|
Its primary activity is in the Biotechnology or Nanotechnology fields and pre-approval is received from the head of research and development at the Office of the Chief Scientist;
|
|
|
2.
|
Its revenue from a specific country is not greater than 75% of its total revenues that year;
|
|
|
3.
|
25% or more of its revenues are derived from a specific foreign market of at least 14 million residents.
|
|
|
(d)
|
Upon the establishment of a “Benefited Enterprise”, an investment of at least NIS 300 thousand in production machinery and equipment within three years is required.
|
|
|
(e)
|
For an expansion, a company is required to invest within three years the higher of NIS 300 thousand in production machinery and equipment or a certain percentage of its existing production machinery and equipment.
|
|
|
C.
|
Tax benefits under the Israeli Law for the Encouragement of Capital Investments, 1959 (hereinafter - the “Law”) (cont'd)
|
|
4.
|
Amendments to the Law (cont'd)
|
|
|
C.
|
Tax benefits under the Israeli Law for the Encouragement of Capital Investments, 1959 (hereinafter - the “Law”) (cont'd)
|
|
4.
|
Amendments to the Law (cont'd)
|
|
D.
|
Tax benefits under the Israeli Law for Encouragement of Industry (Taxes), 1969
|
|
E.
|
Taxation of the subsidiary
|
|
F.
|
Tax assessments
|
|
G.
|
Income before income taxes and income taxes expense (benefit) included in the consolidated statements of operations
|
|
|
Year ended December 31
|
|||||||||||
|
|
2011
|
2012
|
2013
|
|||||||||
|
|
US$ thousands
|
|||||||||||
|
|
|
|
|
|||||||||
|
Income before income taxes:
|
|
|
|
|||||||||
|
Israel
|
8,899 | 10,086 | 16,857 | |||||||||
|
Foreign jurisdiction
|
11 | 695 | 1,125 | |||||||||
|
|
8,910 | 10,781 | 17,982 | |||||||||
|
|
||||||||||||
|
Current taxes:
|
||||||||||||
|
Israel
|
619 | 784 | 949 | |||||||||
|
Foreign jurisdiction
|
- | 116 | 479 | |||||||||
|
|
619 | 900 | 1,428 | |||||||||
|
|
||||||||||||
|
Tax (benefits) expenses relating to prior years:
|
||||||||||||
|
Israel
|
(38 | ) | (12 | ) | 29 | |||||||
|
|
||||||||||||
|
Deferred taxes:
|
||||||||||||
|
Israel
|
73 | (3 | ) | (552 | ) | |||||||
|
Foreign jurisdiction
|
13 | 25 | - | |||||||||
|
|
86 | 22 | (552 | ) | ||||||||
|
|
||||||||||||
|
Income tax expense
|
667 | 910 | 905 | |||||||||
|
H.
|
Deferred income taxes
|
|
|
The tax effects of significant items comprising the Company’s deferred tax assets are as follows:
|
|
|
December 31
|
December 31
|
||||||
|
|
2012
|
2013
|
||||||
|
|
US$ thousands
|
US$ thousands
|
||||||
|
|
|
|
||||||
|
Deferred tax assets:
|
|
|
||||||
|
Accrued employee benefits
|
147 | 248 | ||||||
|
Research and development costs
|
8 | 458 | ||||||
|
PPE
|
5 | 5 | ||||||
|
Other
|
1 | 2 | ||||||
|
Total gross deferred tax assets
|
161 | 713 | ||||||
|
|
||||||||
|
Net deferred tax assets
|
161 | 713 | ||||||
|
|
||||||||
|
Current
|
47 | 274 | ||||||
|
Non-current
|
114 | 439 | ||||||
|
Total
|
161 | 713 | ||||||
|
I.
|
Reconciliation of the statutory tax expense to actual tax expense
|
|
|
Year ended December 31
|
|||||||||||
|
|
2011
|
2012
|
2013
|
|||||||||
|
|
US$ thousands
|
|||||||||||
|
|
|
|
|
|||||||||
|
Income before income taxes
|
8,910 | 10,781 | 17,982 | |||||||||
|
Statutory tax rate in Israel
|
24 | % | 25 | % | 25 | % | ||||||
|
|
2,138 | 2,695 | 4,496 | |||||||||
|
|
||||||||||||
|
Increase (decrease) in taxes resulting from:
|
||||||||||||
|
Non-deductible operating expenses
|
123 | 159 | 205 | |||||||||
|
Prior year adjustments
|
(38 | ) | (12 | ) | 29 | |||||||
|
Change in valuation allowance
|
12 | (63 | ) | - | ||||||||
|
Tax effect due to "Approved Enterprise" status
|
(1,640 | ) | (2,063 | ) | (4,396 | ) | ||||||
|
Taxes related to foreign jurisdictions
|
- | 30 | 198 | |||||||||
|
Changes in tax rate
|
65 | (58 | ) | 399 | ||||||||
|
Other
|
7 | 222 | (26 | ) | ||||||||
|
|
||||||||||||
|
Income tax expense
|
667 | 910 | 905 | |||||||||
|
J.
|
Accounting for uncertainty in income taxes
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|